Related content

Epirubicin and docetaxel as first-line treatment for hormonal receptor positive metastatic breast cancer: the predictive value of luminal subtype: A retrospective cohort analysis

By Nelli Fabrizio   Natoli Guido   Moscetti Luca   Massari Annalisa   D’Auria Giuliana   Fabbri Maria A   Frittelli Patrizia   Ruggeri Enzo M  

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 112-118

Maney Publishing

Access to resources Recommend Favorite

Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women

By Agboola A.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 555-569

Springer Publishing Company

Access to resources Recommend Favorite

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype

By  

Cancer Medicine, Vol. 4, Iss. 7, 2015-07 ,pp. : 1016-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications

By Mohammed Rabab  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 261-273

Springer Publishing Company

Access to resources Recommend Favorite

RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype

By Habashy Hany  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 315-326

Springer Publishing Company

Access to resources Recommend Favorite